Chronic obstructive pulmonary disease and community acquired pneumonia: Additional studies are required

被引:0
|
作者
de Miguel-Diez, Javier [1 ]
Lopez-de-Andres, Ana [2 ]
Hernandez-Barrera, Valentin [2 ]
Jimenez-Trujillo, Isabel [2 ]
Mendez-Bailon, Manuel [3 ]
de Miguel-Yanes, Jose Maria [4 ]
Jimenez-Garcia, Rodrigo [2 ]
机构
[1] UCM, Hosp Gen Univ Gregorio Maranon, Fac Med, Inst Invest Sanitaria Gregorio Maranon IiSGM,Resp, Madrid, Spain
[2] Rey Juan Carlos Univ, Hlth Sci Fac, Prevent Med & Publ Hlth Teaching & Res Unit, Madrid, Spain
[3] Hosp Univ Clin San Carlos, Internal Med Dept, Madrid, Spain
[4] Univ Gregorio Maranon, Gen Hosp, Internal Med Dept, Madrid, Spain
关键词
COPD; METAANALYSIS; GUIDELINES; MORTALITY;
D O I
10.1016/j.ejim.2018.01.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E39 / E40
页数:2
相关论文
共 50 条
  • [31] The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study
    Ruo-Xuan Dai
    Qing-Hua Kong
    Bei Mao
    Wen Xu
    Ru-Jia Tao
    Xiao-Ru Wang
    Qing-Yao Kong
    Jin-Fu Xu
    BMC Pulmonary Medicine, 18
  • [32] Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes
    Bordon, J.
    Slomka, M.
    Gupta, R.
    Furmanek, S.
    Cavallazzi, R.
    Sethi, S.
    Niederman, M.
    Ramirez, J. A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (02) : 220 - 226
  • [33] The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study
    Dai, Ruo-Xuan
    Kong, Qing-Hua
    Mao, Bei
    Xu, Wen
    Tao, Ru-Jia
    Wang, Xiao-Ru
    Kong, Qing-Yao
    Xu, Jin-Fu
    BMC PULMONARY MEDICINE, 2018, 18
  • [34] A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease
    Huang, Dong
    He, Dingxiu
    Gong, Linjing
    Yao, Rong
    Wang, Wen
    Yang, Lei
    Zhang, Zhongwei
    He, Qiao
    Wu, Zhenru
    Shi, Yujun
    Liang, Zongan
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [35] A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease
    Dong Huang
    Dingxiu He
    Linjing Gong
    Rong Yao
    Wen Wang
    Lei Yang
    Zhongwei Zhang
    Qiao He
    Zhenru Wu
    Yujun Shi
    Zongan Liang
    Respiratory Research, 23
  • [36] Dynamics of the lung microbiome in intensive care patients with chronic obstructive pulmonary disease and community-acquired pneumonia
    Wei-Chang Huang
    Ming-Feng Wu
    Chen-Cheng Huang
    Sin-Yin Liu
    Hui-Chen Chen
    Yih-Yuan Chen
    Jeng-Yuan Hsu
    Chieh-Chen Huang
    Scientific Reports, 10
  • [37] Clinical Features, Medical Costs And Radiographic Resolution Of Community-Acquired Pneumonia In Patients With Chronic Obstructive Pulmonary Disease
    Yoshida, K.
    Teramoto, S.
    Hizawa, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [38] A prospective study of community acquired pneumonia related exacerbation of chronic obstructive pulmonary disease and its impact on morbidity and mortality
    Mcleod, K.
    Ponnuswamy, A.
    Kedia, R. K.
    Winson, M. D.
    THORAX, 2006, 61 : II28 - II28
  • [39] Ertapenem as initial antimicrobial monotherapy for patients with chronic obstructive pulmonary disease hospitalized with typical community-acquired pneumonia
    Friedland, IR
    McCarroll, KA
    DiNubile, MJ
    Woods, GL
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2004, 17 (04) : 199 - 203
  • [40] Chronic obstructive pulmonary disease and drug-resistant pseudomonas in patients hospitalized with community-acquired bacterial pneumonia
    Idigo, Adeniyi J.
    Wells, J. Michael
    Brown, Matthew L.
    Wiener, Howard
    Griffin, Russell
    Cutter, Gary R.
    Shrestha, Sadeep
    Lee, Rachael A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 167 - 167